Gurnet Point Capital’s diverse team brings more than 100 years of combined operational experience within life sciences and a strong track record of investing, building value and successfully monetizing late-stage life sciences businesses. The firm also leverages the support and infrastructure of the B-FLEXION group and a network of over 200 operational advisors.
